DE69632152D1 - N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung - Google Patents

N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung

Info

Publication number
DE69632152D1
DE69632152D1 DE69632152T DE69632152T DE69632152D1 DE 69632152 D1 DE69632152 D1 DE 69632152D1 DE 69632152 T DE69632152 T DE 69632152T DE 69632152 T DE69632152 T DE 69632152T DE 69632152 D1 DE69632152 D1 DE 69632152D1
Authority
DE
Germany
Prior art keywords
carbon atoms
denotes
groups
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69632152T
Other languages
English (en)
Other versions
DE69632152T2 (de
Inventor
Toshio Maeda
Masahiro Nomura
Katsuya Awano
Susumu Kinoshita
Hiroya Satoh
Koji Murakami
Masaki Tsunoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69632152D1 publication Critical patent/DE69632152D1/de
Publication of DE69632152T2 publication Critical patent/DE69632152T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69632152T 1995-12-18 1996-12-16 N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung Expired - Fee Related DE69632152T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34834195 1995-12-18
JP34834195A JP3906935B2 (ja) 1995-12-18 1995-12-18 Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
PCT/JP1996/003664 WO1997022600A1 (fr) 1995-12-18 1996-12-16 Derives de la dioxothiazolidylbenzamide substitues en n et leur procede d'obtention

Publications (2)

Publication Number Publication Date
DE69632152D1 true DE69632152D1 (de) 2004-05-13
DE69632152T2 DE69632152T2 (de) 2005-02-24

Family

ID=18396383

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632152T Expired - Fee Related DE69632152T2 (de) 1995-12-18 1996-12-16 N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung

Country Status (12)

Country Link
US (1) US5948803A (de)
EP (1) EP0881219B1 (de)
JP (1) JP3906935B2 (de)
KR (1) KR100492655B1 (de)
CN (1) CN1065863C (de)
AT (1) ATE263759T1 (de)
AU (1) AU705538B2 (de)
CA (1) CA2239245C (de)
DE (1) DE69632152T2 (de)
HU (1) HUP0000449A3 (de)
TW (1) TW339333B (de)
WO (1) WO1997022600A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147101A (en) * 1995-06-02 2000-11-14 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same
WO1998020871A1 (fr) * 1996-11-08 1998-05-22 Nippon Chemiphar Co., Ltd. Agent diminuant la graisse viscerale
WO1999032465A1 (en) * 1997-12-19 1999-07-01 Merck & Co., Inc. Arylthiazolidinedione derivatives
US6008237A (en) 1997-12-19 1999-12-28 Merck & Co., Inc. Arylthiazolidinedione derivatives
EP1194146B1 (de) * 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione und aryloxa zolidinedion-derivate
EP1194147B1 (de) 1999-06-18 2007-01-10 Merck & Co., Inc. Arylthiazolidindion- und aryloxazolidinderivate
WO2001014350A1 (fr) * 1999-08-23 2001-03-01 Kyorin Pharmaceutical Co., Ltd. Derives de benzylthiazolidine-2,4-dione substitues
DE60020375T2 (de) 1999-08-23 2006-11-23 Kyorin Pharmaceutical Co., Ltd. Substituierte benzylthiazolidin-2,4-dion derivate
WO2001014349A1 (fr) * 1999-08-23 2001-03-01 Kyorin Pharmaceutical Co., Ltd. Derives de benzylthiazolidine-2,4-dione substitues
ATE316071T1 (de) * 1999-09-17 2006-02-15 Kyorin Seiyaku Kk O-anisamid-derivate
AU2002222574A1 (en) 2000-12-05 2002-06-18 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
US7329782B2 (en) * 2001-06-12 2008-02-12 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
PA8557501A1 (es) 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
ITRM20020016A1 (it) * 2002-01-15 2003-07-15 Sigma Tau Ind Farmaceuti Derivati di acidi fenil(alchil)carbossilici e derivati fenilalchileterociclici dionici, loro uso come medicamenti ad attivita' ipoglicemizza
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
ATE355273T1 (de) 2003-05-12 2006-03-15 Pfizer Prod Inc Benzamidinhibitoren des p2x7-rezeptors
EP1837330B1 (de) * 2003-05-12 2012-10-24 Pfizer Products Inc. Benzamidinhibitoren des P2X7-Rezeptors
AU2005258924A1 (en) * 2004-06-29 2006-01-12 Pfizer Products Inc. Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-`1,2,4!-triazin-2-YK!benzamide derivatives with P2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid
JP2008504363A (ja) * 2004-06-29 2008-02-14 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー Ｐ２ｘ７受容体のベンズアミド阻害剤を利用する併用療法
EP1776352A1 (de) * 2004-06-29 2007-04-25 Pfizer Products Inc. Verfahren zur herstellung von 5-[4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h[1,2,4]triazin-2-yl]benzamidderivativen durch entschützen der hydroxylgeschützten vorstufen
AU2007220868B2 (en) * 2006-02-28 2011-06-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
WO2011160206A1 (en) 2010-06-23 2011-12-29 Morin Ryan D Biomarkers for non-hodgkin lymphomas and uses thereof
HUE028977T2 (en) 2010-09-10 2017-02-28 Epizyme Inc A method for determining the suitability of human EZH2 inhibitors during treatment
US9175331B2 (en) 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
WO2012118812A2 (en) 2011-02-28 2012-09-07 Epizyme, Inc. Substituted 6,5-fused bicyclic heteroaryl compounds
TWI598336B (zh) 2011-04-13 2017-09-11 雅酶股份有限公司 經取代之苯化合物
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
EP2836491B1 (de) 2012-04-13 2016-12-07 Epizyme, Inc. Salzform eines menschlichen histonmethyltransferase-ezh2-inhibitors
US9006242B2 (en) 2012-10-15 2015-04-14 Epizyme, Inc. Substituted benzene compounds
DK3057962T3 (da) 2013-10-16 2023-11-06 Epizyme Inc Hydrochloridsaltform til ezh2-hæmning
CN108929263B (zh) * 2017-05-26 2022-07-22 中国医学科学院药物研究所 芳酰胺类Kv2.1抑制剂及其制备方法、药物组合物和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6610081A (en) * 1980-01-24 1981-07-30 Senju Pharmaceutical Co., Ltd. Thiazolidine derivatives
JPS5728073A (en) * 1980-07-29 1982-02-15 Takeda Chem Ind Ltd Inhibitor for aldose reducing enzyme
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
HU217432B (hu) * 1988-03-08 2000-01-28 Pfizer Inc. Eljárás tiazolidin-dion-származékok és az ezeket tartalmazó gyógyszerkészítmények előállítására, a vegyületek és a készítmények
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
JP3053490B2 (ja) * 1991-02-25 2000-06-19 杏林製薬株式会社 チアゾリジン−２，４−ジオン誘導体とその塩及び製造法
JPH04270273A (ja) * 1991-02-25 1992-09-25 Kyorin Pharmaceut Co Ltd チアゾリジン−２，４−ジオン誘導体とその塩及びその製造法
FR2696743B1 (fr) * 1992-10-12 1994-12-23 Adir Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
KR100492655B1 (ko) 2005-09-07
EP0881219A4 (de) 2000-01-26
HUP0000449A3 (en) 2001-04-28
AU705538B2 (en) 1999-05-27
ATE263759T1 (de) 2004-04-15
CN1065863C (zh) 2001-05-16
HUP0000449A2 (hu) 2001-02-28
JP3906935B2 (ja) 2007-04-18
DE69632152T2 (de) 2005-02-24
EP0881219B1 (de) 2004-04-07
JPH09169746A (ja) 1997-06-30
AU2011697A (en) 1997-07-14
CN1205695A (zh) 1999-01-20
EP0881219A1 (de) 1998-12-02
US5948803A (en) 1999-09-07
CA2239245C (en) 2004-03-30
KR20000064428A (ko) 2000-11-06
TW339333B (en) 1998-09-01
CA2239245A1 (en) 1997-06-26
WO1997022600A1 (fr) 1997-06-26

Similar Documents

Publication Publication Date Title
DE69632152D1 (de) N-substituierte dioxothiazolidyl-benzamid-derivate und verfahren zu ihrer herstellung
DE69618792T2 (de) N-benzyldioxothiazolidylbenzamid-derivate und verfahren zu ihrer herstellung
DE68906552D1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung.
ATE229960T1 (de) Verfahren zur herstellung von 13-ether-derivaten von milbemycinen und zwischenprodukte
DE3871190D1 (de) Polymerisationsverfahren und polymerisationskatalysator.
DE69411243D1 (de) Verfahren zur herstellung eines lignan-derivats
ATE164582T1 (de) 1-methylcarbapenemderivate und verfahren zu ihrer herstellung
DK0488513T3 (da) Anvendelse af dioxabicyclo(3.3.0)octanderivater til fremstilling af et medikament til inhibering af cholesterolmetabolismen
ATE143354T1 (de) N-alkoxymethylbenzamid-derivate und verfahren zu ihrer herstellung und ihre verwendung zur herstellung von benzamid-derivaten
DE69517201T2 (de) Verfahren zur herstellung von 2-(2-hydroxymethylphenyl)acetamid-derivaten und zwischenprodukte zur herstellung
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
ATE270287T1 (de) 2,3-dihydro-1h-isoindolderivate, verfahren zu ihrer herstellung und ihre verwendung als hemmer der serotoninwiederaufnahme
ATE168371T1 (de) 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE118762T1 (de) Verfahren zur herstellung von 4- methylsulfonylbenzoesäurederivate und zwischenprodukte.
ATE141583T1 (de) Alpha-methylencyclopentanon-derivate und verfahren zu ihrer herstellung
AU7332996A (en) Therapeutics for thrombocytopenia
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
ATE236109T1 (de) Verfahren zur herstellung von 1,5-pentandiol- derivaten
HUT47929A (en) Process for producing 4-piperidine-carboxamide derivatives and pharmaceuticals comprising same
DE69129605D1 (de) Verfahren zur Herstellung von N-Alkylpyrazolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee